• manage heart risk 2016
  • video series 2016
  • info-sheets-2016
Menopause - what are the symptoms
Is Menopausal Hormone Therapy (HRT) safe?
Menopause - Non-hormonal Treatment Options

What's New?

  • Members update

    HRT, dry eyes and other ocular manifestations; Recent studies on natural alternatives to hormone therapy;  Our Menopause World November 2016; New guidelines for risk assessment, diagnosis and treatment of postmenopausal osteoporos...
  • Cardiovascular risk assessment in women – an update

    Cardiovascular disease is the leading cause of morbidity and mortality in postmenopausal women. Although it is a disease of aging, vascular disease initiates much earlier in life. Thus, there is a need to be aware of the potential to prevent the dev...
  • Sex after menopause - survey

    New survey shows women still don't understand why sex hurts after menopause Women's EMPOWER survey confirms reluctance to discuss sex problems and seek treatment despite major educational efforts The Women's EMPOWER survey, an internet-based survey...
  • Are natural alternatives to estrogen replacement therapy safe?

    Although individuals often consume natural products because of their potential health benefits, a review indicates that it is not clear whether the benefits of plant-derived compounds that mimic estrogen outweigh the possible health risks.  P...
  • Heart Health Matters: World Menopause Day 2016

    The theme of this year’s World Menopause Day on 18 October is “Heart Health Matters”.  “Do what makes your heart healthy” says Professor Bronwyn Stuckey, President of the Australasian Menopause Society.  “Although menopause is natural in mo...
  • Migraine and cardiovascular risk in the menopause

    8 August, 2016:  Long ago it was perceived that migraineurs have a higher risk for ischemic stroke, mainly because of short-term pro-thrombotic alterations during attacks [1, 2]. Migraine with aura confers a lifelong 2–2.5-fold elevated risk of...
  • Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?

    ...Professor Baber (International Menopause Society President) concludes “This new observational study, with the best of intentions, remains an observational study with small numbers of breast cancer cases and dose not change our overall understandin...

Features

  • Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016

    American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016  Osteoporosis is preventable and treatable, but only a sm...
  • Revised Global Consensus Statement on Menopausal Hormone Therapy

    This Consensus Statement is endorsed by The International Menopause Society, The North American Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The Asia Pacific Menopause Federation, The International Osteopor...
  • Sexual difficulties in the menopause

    Key Points Sexual difficulties can be life-long or recently acquired, but they are a common presentation at menopause. Hormones are rarely the only factor involved in desire-arousal problems. Declining sexual function correlates with fal...
  • A model of care for healthy menopause and ageing: EMAS position statement

    Key points:  The conceptual framework of the Healthy Menopause and Ageing is a holistic model of care incorporating disease and disability. Healthcare model's core: lead clinician, specialist nurse, patient, interdisciplinary network of heal...
  • Are women suffering in silence? - UK survey

    New survey puts spotlight on significant impact of menopause despite recent guideline Findings presented at the British Menopause Society’s annual conference show only half of women surveyed in Great Britain (who are currently experiencing or who ha...
  • Early use of postmenopausal hormone therapy may prevent heart disease

    Findings suggest that after decades of research regarding the effectiveness of MHT on heart disease, timing may be everything:  Hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis, ...
  • Know your bones

    Bone fracture risk assessment:  An Australian-first bone health self-assessment tool designed to help consumers understand their bone fracture risk has been produced by Osteoporosis Australia and Garvan Institute of Medical Research. www.knowy...
cialis